Search

everythinglearnresearchcommunity

for

Search:↓

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Bicalutamide may help treat female pattern hair loss.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Testosterone helps human pancreatic cells increase insulin release.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Fulvestrant at 10 mg/kg does not promote hair regrowth in dogs with alopecia X.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Women with high androgen levels may have more severe COVID-19 symptoms.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Medications for PCOS don't seem to raise heart disease risk.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.